bradykinin
Showing 1 - 8 of 8
Prehypertension, Hypertension Trial in Boulder (Nebivolol, Metoprolol, Placebo)
Completed
- Prehypertension
- Hypertension
- Nebivolol
- +5 more
-
Boulder, ColoradoUC-Boulder Clinical and Translational Research Center
Jun 5, 2019
Hyperlipidemia Trial in Atlanta (Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin)
Terminated
- Hyperlipidemia
- Tetraethylammonium (TEA)
- +6 more
-
Atlanta, GeorgiaEmory University School of Medicine
Jul 17, 2018
Coronary Artery Disease Trial in Nashville (Bradykinin)
Terminated
- Coronary Artery Disease
- Bradykinin
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 11, 2017
Heart Transplantation Trial in Nashville (Bradykinin)
Withdrawn
- Heart Transplantation
- Bradykinin
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 16, 2017
Obesity Trial in Nashville (Bradykinin)
Terminated
- Obesity
- Bradykinin
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 13, 2017
Healthy Trial in Nashville (Bradykinin, Aspirin 81 mg, Aspirin 162 mg)
Completed
- Healthy
- Bradykinin
- +5 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 3, 2016
Heart Transplantation Trial in Nashville (Bradykinin)
Withdrawn
- Heart Transplantation
- Bradykinin
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 14, 2016
Hypertension, Diabetes Type 2 Trial in Nashville (Sitagliptin (DPP4 inhibitor), Substance P,, bradykinin)
Completed
- Hypertension
- Diabetes Type 2
- Sitagliptin (DPP4 inhibitor)
- +5 more
-
Nashville, TennesseeVanderbilt University- General Clinic Research Center
Oct 5, 2015